FrancophonIA/ELRC3.0 huggingface dataset:
English: Summary of the safety profile in psoriatic arthritis
Slovenian: Povzetek varnostnega profila pri psoriaznem artritisu
English: It is recommended that patients with juvenile idiopathic arthritis be brought up to date with all immunizations in agreement with current immunization guidelines prior to initiating ORENCIA therapy (see section 4.5).
Slovenian: Pri bolnikih z juvenilnim idiopatskim artritisom je pred uvedbo zdravljenja z zdravilom ORENCIA priporočljivo opraviti vsa priporočena cepljenja v skladu s trenutno veljavnimi smernicami za cepljenje (glejte poglavje 4.5).
English: Front of thighs
Slovenian: Prednji del stegen
English: At 24 months, 50.6% (127/251) [95% CI: 44.4, 56.8] of patients in abatacept and 53.3% (130/244) [95% CI: 47.0, 59.5] of patients in adalimumab groups achieved DAS 28 < 2.6.
Slovenian: Po 24 mesecih je 50,6 % (127/251) [95 % IZ: 44,4; 56,8] bolnikov v skupini z abataceptom in 53,3 % (130/244) [95 % IZ: 47,0; 59,5] bolnikov v skupini z adalimumabom doseglo DAS 28 < 2,6.
English: Keep any remaining unused syringes in their original carton, in the refrigerator.
Slovenian: Preostale, še neuporabljene napolnjene injekcijske brizge pustite v hladilniku v originalni ovojnini.
English: Flare was defined as: ≥ 30% worsening in at least 3 of the 6 pJIA core set variables ≥ 30% improvement in not more than 1 of the 6 pJIA core set variables ≥ 2 cm (possible up to 10 cm) of worsening must have been present if the Physician or Parent Global Assessment was used to define flare worsening in ≥ 2 joints must have been present if the number of active joints or joints with limited range of motion was used to define flare
Slovenian: Poslabšanje je bilo definirano kot: ≥ 30% poslabšanje pri vsaj 3 od 6 ključnih spremenljivk pJIA ≥ 30% izboljšanje pri ne več kot 1 od 6 ključnih spremenljivk pJIA če se je za definicijo poslabšanja uporabila globalna ocena zdravnika ali starša, je moralo biti prisotno poslabšanje za ≥ 2 cm (možno do 10 cm); če se je za definicijo poslabšanja uporabilo število aktivno prizadetih sklepov ali sklepov z omejeno gibljivostjo, je moralo biti prisotno poslabšanje pri ≥ 2 sklepih.
English: Remove the ClickJect Pre-filled Pen from the injection site by lifting it straight up.
Slovenian: Odstranite ClickJect napolnjen injekcijski peresnik iz mesta injiciranja tako, da ga dvignete naravnost navzgor.
English: In a one-year toxicity study in cynomolgus monkeys, abatacept was not associated with any significant toxicity.
Slovenian: Pri enoletni študiji toksičnosti na opicah cinomolgus niso odkrili pomembnejšega toksičnega delovanja abatacepta.
English: It is important that you tell your baby's doctors and other health care professionals about your ORENCIA use during your pregnancy before the baby receives any vaccine (for more information see section on vaccination).
Slovenian: Pomembno je, da otrokovega zdravnika in drugo zdravstveno osebje, ki skrbi za otroka, obvestite o uporabi zdravila ORENCIA med nosečnostjo, preden otrok prejme katero koli cepivo (za več informacij glejte poglavje o cepljenju).
English: This medicinal product contains 34.5 mg sodium per maximum dose of 4 vials (8.625 mg sodium per vial), equivalent to 1.7% of the WHO recommended maximum daily intake of 2 g sodium for an adult.
Slovenian: To zdravilo vsebuje 34,5 mg natrija na največji odmerek 4 viale (8,625 mg natrija na vialo), kar je enako 1,7 % največjega dnevnega vnosa natrija za odrasle osebe, ki ga priporoča SZO in znaša 2 g.
English: In people with rheumatoid arthritis the body's own immune system attacks normal body tissues, leading to pain and swelling of the joints.
Slovenian: Pri bolnikih z revmatoidnim artritisom imunski sistem organizma napade normalna telesna tkiva, kar povzroči bolečino in oteklino sklepov ter lahko vodi do poškodbe sklepov.
English: In study II, the baseline median TSS was 31.7 in abatacept-treated patients and 33.4 in placebo-treated patients.
Slovenian: V študiji II je bila srednja izhodiščna vrednost TSS pri bolnikih, ki so prejemali abatacept 31,7, pri bolnikih, ki so prejemali placebo, pa 33,4.
English: There was a significant improvement of DAS in studies II, III, V, and VI as compared to placebo or comparator.
Slovenian: V študijah II, III, V in VI so opazili pomembno izboljšanje DAS v primerjavi s placebom ali primerjalnim zdravilom.
English: Component of a multipack, can't be sold separately.
Slovenian: Del skupnega pakiranja, izdaja posamezne enote ni možna.
English: A. Choose an area of your body for the injection (injection site) You can use: o the front of your thigh o your abdomen, except for the 5 cm area around the navel (Figure 3).
Slovenian: A. Izberite predel telesa, kamor si boste injicirali zdravilo (mesto injiciranja) Zdravilo si lahko injicirate pod kožo na: o sprednjem delu stegna o trebuhu, razen v predelu 5 cm okrog popka (slika 3).
English: At 12 months 61% (148/242) of the patients treated with abatacept plus methotrexate and 53% (128/242) of the patients treated with methotrexate plus placebo had no progression (TSS ≤ 0).
Slovenian: Po 12 mesecih 61% (148/242) bolnikov, ki so se zdravili z abataceptom in metotreksatom, in 53% (128/242) bolnikov, ki so se zdravili z metotreksatom in placebom, ni imelo progresije (TSS ≤ 0).
English: Doctor's Name: ____________________
Slovenian: Ime in priimek zdravnika:
English: The incidence rate in abatacept-treated patients was 3.8 per 100 person-years in the cumulative period.
Slovenian: V kumulativnem obdobju je stopnja pojavnosti pri bolnikih, ki so prejemali abatacept, znašala 3,8 na 100 bolnik-let.
English: Contact your doctor or pharmacist for assistance.
Slovenian: Za pomoč se obrnite na svojega zdravnika ali farmacevta.
English: Anti-abatacept antibodies were generally transient and of low titer.
Slovenian: Protitelesa proti abataceptu so bila v glavnem prehodna in nizkih titrov.
English: Table 8:
Slovenian: Preglednica 8:
English: No evidence of lymphomas or preneoplastic morphological changes was observed, despite the presence of a virus, lymphocryptovirus, which is known to cause such lesions in immunosuppressed monkeys within the time frame of this study.
Slovenian: V časovnem okviru študije niso opazili znakov limfomov ali preneoplastičnih morfoloških sprememb, kljub prisotnosti limfokriptovirusa, ki pri imunsko oslabljenih opicah dokazano povzroča tovrstne spremembe.
English: ORENCIA contains maltose, which is a type of sugar that can give falsely high blood glucose readings with certain types of blood glucose monitors.
Slovenian: Zdravilo ORENCIA vsebuje maltozo, vrsto sladkorja, ki lahko pri uporabi nekaterih tipov merilcev krvnega sladkorja povzroči lažno visoke odčitke vrednosti krvnega sladkorja.
English: Abatacept was also evaluated in an open-label study in rheumatoid arthritis patients administered the seasonal influenza trivalent virus vaccine.
Slovenian: Abatacept so vrednotili tudi v odprti študiji pri bolnikih z revmatoidnim artritisom, ki so prejeli trivalentno virusno cepivo proti sezonski gripi.
English: Abatacept was evaluated in an open-label study in rheumatoid arthritis patients administered the 23valent pneumococcal vaccine.
Slovenian: Abatacept so vrednotili v odprti študiji pri bolnikih z revmatoidnim artritisom, ki so prejeli 23valentno cepivo proti pnevmokokom.
English: When the intravenous loading dose was not administered, a mean trough concentration of 12.6 mcg/mL was achieved after 2 weeks of dosing.
Slovenian: Če začetni intravenski odmerek ni bil dan, je bila najmanjša koncentracija v stanju dinamičnega ravnovesja 12,6 μg/ml dosežena po 2 tednih zdravljenja.
English: Hold the syringe by its body in one hand, and pull the needle cover straight off with your other hand (Figure 4).
Slovenian: Z eno roko primite injekcijsko brizgo za njeno telo, z drugo roko pa primite pokrovček igle in ga naravnost potegnite z igle (slika 4).
English: During Period B, the time to disease flare for the patients randomised to placebo was significantly shorter than for those randomised to abatacept (primary endpoint, p=0.0002; log-rank test).
Slovenian: Med obdobjem B študije je bil čas do poslabšanja bolezni pri bolnikih, ki so bili randomizirani na placebo, pomembno krajši kot pri bolnikih, ki so bili randomizirani na abatacept (primarni izid, p=0,0002; log-rank test).
English: Step 4: Choose and Prepare an Injection Site Choose your injection site in either the abdomen, front of the thighs, or outer area of upper arm (only if caregiver administered).
Slovenian: 4. korak: Izbira in priprava mesta za injiciranje Izberite mesto injiciranja na trebuhu, sprednjem delu stegna ali zunanjem predelu nadlakti (le, če se zdravilo aplicira s pomočjo druge osebe).
English: The other ingredients are maltose, sodium dihydrogen phosphate monohydrate and sodium chloride (see section 2 "ORENCIA contains sodium").
Slovenian: Druge sestavine zdravila so maltoza, natrijev dihidrogenfosfat monohidrat in natrijev klorid (glejte poglavje 2 "Zdravilo ORENCIA vsebuje natrij").
English: *(e.g. pruritus, throat tightness, dyspnea)
Slovenian: *(npr. srbenje, stiskanje v grlu, dispneja)
English: Less than 60 kg
Slovenian: Manj kot 60 kg
English: if you become pregnant while using ORENCIA, tell your doctor.
Slovenian: Če med zdravljenjem z zdravilom ORENCIA zanosite, to povejte svojemu zdravniku.
English: Patients achieving at least a ACR Pedi 30 response at the end of Period A were randomised into a double-blind, withdrawal phase (Period B), and received either abatacept or placebo for 6 months or until pJIA disease flare as defined in the study.
Slovenian: Bolniki, ki so na koncu obdobja A dosegli odziv vsaj ACR Pedi 30, so bili randomizirani v dvojno slepo odtegnitveno fazo (obdobje B) in prejemali abatacept ali placebo 6 mesecev ali dokler se ni stanje pJIA poslabšalo kot je bilo določeno v študiji.
English: Summary of the safety profile in rheumatoid arthritis
Slovenian: Povzetek varnostnega profila pri revmatoidnem artritisu
English: The overall safety profile was comparable between studies PsA-I and PsA-II and consistent with the safety profile in rheumatoid arthritis (Table 1).
Slovenian: Celokupen varnostni profil je bil med študijama PsA-I in PsA-II primerljiv in skladen z varnostnim profilom pri revmatoidnem artritisu (preglednica 1).
English: Respiratory disorders occurred more frequently in abatacept-treated patients than in placebo-treated patients (10.8% vs. 5.9%, respectively); these included COPD exacerbation, and dyspnea.
Slovenian: Bolezni dihal so bile pri bolnikih, ki so prejemali abatacept, pogostejše kot pri bolnikih, ki so prejemali placebo (10,8% v primerjavi s 5,9%), in so vključevale poslabšanje KOPB in dispnejo.
English: Once you remove it from your skin, the transparent tip will lock over the needle.
Slovenian: Ko ga boste izvlekli iz kože, bo prozorna konica obdala in zavarovala iglo.
English: Keep track of your next dose.
Slovenian: Vodite evidenco kdaj morate uporabiti naslednji odmerek.
English: If you do not respond well enough to these medicines, you may be given ORENCIA to:
Slovenian: Če odziv na zdravljenje z drugimi zdravili ne bo zadosten, vam zdravnik lahko predpiše zdravljenje z zdravilom ORENCIA za:
English: Children weighing 75 kg or more should be administered ORENCIA powder for concentrate for solution for infusion following the adult dosing regimen.
Slovenian: Otroci s telesno maso 75 kg ali večjo, morajo zdravilo ORENCIA prašek za koncentrat za raztopino za infundiranje prejeti v skladu z režimom odmerjanja za odrasle.
English: ORENCIA is used to: slow down the damage to joints improve physical function improve other signs and symptoms of polyarticular juvenile idiopathic arthritis
Slovenian: Zdravilo ORENCIA uporabljamo za: upočasnitev napredovanja poškodb sklepov izboljšanje telesne zmogljivosti, izboljšanje drugih znakov in simptomov poliartikularnega juvenilnega idiopatskega artritisa.
English: Medicinal products that affect the immune system, including abatacept, may blunt the effectiveness of some immunisations.
Slovenian: Zdravila, ki vplivajo na imunski sistem, vključno z abataceptom, lahko zmanjšajo učinkovitost nekaterih cepljenj.
English: There may be a little bleeding at the injection site.
Slovenian: Na mestu injiciranja se lahko pojavi blaga krvavitev.
English: The safety and efficacy of intravenous ORENCIA in children below 6 years of age have not been studied and therefore, intravenous ORENCIA is not recommended for use in children under six years old.
Slovenian: Varnosti in učinkovitosti intravenske uporabe zdravila ORENCIA pri otrocih, mlajših od 6 let, niso raziskovali, zato intravenska uporaba zdravila ORENCIA pri otrocih, mlajših od šest let, ni priporočljiva.
English: Age and gender (when corrected for body weight) did not affect apparent clearance.
Slovenian: Starost in spol (če sta bila korigirana glede na telesno maso) nista vplivala na navidezni očistek.
English: Pull orange needle cover STRAIGHT off.
Slovenian: Oranžni pokrovček igle potegnite NARAVNOST in ga odstranite.
English: However, if you are feeling tired or unwell after receiving ORENCIA, you should not drive or operate any machinery.
Slovenian: Kljub temu pa v primeru, da se po prejemu zdravila ORENCIA počutite utrujeni ali se slabo počutite, ne smete voziti vozil ali upravljati s stroji.
English: Juvenile rats seemed to be more sensitive to lymphocytic inflammation of thyroid.
Slovenian: Zdi se, da so bili mladiči podgan bolj dovzetni za limfocitna vnetja ščitnice.
English: ORENCIA has not been studied in these patient populations.
Slovenian: Pri teh skupinah bolnikov uporabe zdravila ORENCIA niso raziskovali.
English: ORENCIA selectively modulates the activation of T cells involved in the immune system's inflammatory response.
Slovenian: Zdravilo ORENCIA selektivno uravnava aktivacijo celic T. Celice T sodelujejo pri vnetnem odzivu imunskega sistema.
English: The overall safety profile was comparable between studies PsA-I and PsA-II and consistent with the safety profile in rheumatoid arthritis (Table 2).
Slovenian: Celokupen varnostni profil je bil med študijama PsA-I in PsA-II primerljiv in skladen z varnostnim profilom pri revmatoidnem artritisu (preglednica 2).
English: You may use the same thigh for weekly injections, as long as each injection site is approximately 2.5 cm away from where you last injected.
Slovenian: Zdravilo lahko vsak teden injicirate v isto stegno, vendar pa mora biti novo mesto injiciranja od predhodnega oddaljeno približno 2,5 cm.
English: Uncommon Palpitations, tachycardia, bradycardia
Slovenian: Srčne bolezni občasni palpitacije, tahikardija, bradikardija
English: Insert the needle with a quick motion into the pinched skin at a 45° angle (Figure 5).
Slovenian: V stisnjen predel kože s hitrim gibom zabodite iglo pod kotom 45° (slika 5).
English: At the start, your doctor or nurse may inject ORENCIA.
Slovenian: Na začetku vam bo zdravilo ORENCIA injiciral zdravnik ali medicinska sestra.
English: When reconstitution and dilution are performed under aseptic conditions ORENCIA infusion solution can be used immediately or within 24 hours if stored refrigerated at 2°C to 8°C.
Slovenian: Če sta rekonstitucija in redčenje izvedena v aseptičnih pogojih, se ORENCIA raztopino za infundiranje lahko uporabi takoj ali v 24 urah, če se jo shrani pri temperaturi od 2 °C do 8 °C.
English: During the first 4-month treatment period of intravenous and subcutaneous abatacept in 409 patients with pJIA, the most common adverse reactions were nasopharyngitis (3.7% patients) and upper respiratory tract infection (2.9% patients).
Slovenian: Med prvimi 4 meseci intravenskega in subkutanega zdravljenja z abataceptom so bili pri 409 bolnikih s pJIA najpogostejši neželeni učinki nazofaringitis (3,7% bolnikov) in okužba zgornjih dihal (2,9% bolnikov).
English: Don't press on the plunger head until you begin your injection.
Slovenian: Na glavo bata ne smete pritisniti, dokler zdravila ne začnete injicirati.
English: If you are already on intravenous ORENCIA treatment and wish to transition to ORENCIA subcutaneous, you should receive a subcutaneous injection instead of your next intravenous infusion, followed by weekly subcutaneous injections of ORENCIA.
Slovenian: Če se z zdravilom ORENCIA že zdravite intravensko in boste zdravljenje zamenjali za podkožno, morate podkožno injekcijo prejeti namesto naslednje intravenske infuzije, nato pa podkožne injekcije zdravila ORENCIA prejemati enkrat na teden.
English: B. Position the syringe and inject ORENCIA Hold the syringe by its body in one hand between your thumb and index finger (Figure 5).
Slovenian: B. Namestitev injekcijske brizge in injiciranje zdravila ORENCIA S palcem in kazalcem ene roke primite brizgo za njeno telo (slika 5).
English: At 24 months, 20.8 % (66/318) of patients on abatacept and 25.3 % (83/328) on adalimumab had discontinued.
Slovenian: V 24 mesecih je bilo zdravljenje prekinjeno pri 20,8 % (66/318) bolnikov, ki so se zdravili z abataceptom, in 25,3 % (83/328) bolnikov, ki so se zdravili z adalimumabom.
English: Position the ClickJect Pen so you can see the viewing window and it's at a 90º angle to the injection site.
Slovenian: Injekcijski peresnik ClickJect primite tako, da vidite nadzorno okence in ga namestite na mesto injiciranja pod kotom 90º.
English: Uncommon (may affect up to 1 in 100 people): blood in urine ear infection
Slovenian: Občasni (pojavijo se lahko pri največ 1 od 100 bolnikov): kri v urinu, okužbe ušes
English: Should you have any questions, ask your pharmacist.
Slovenian: Če imate o tem kakršno koli vprašanje, se posvetujte s farmacevtom.
English: In this study children and adolescents with moderately to severely active pJIA, ages 2 to 17 years (46 patients in the 2 to 5 year age cohort and 173 patients in the 6 to 17 year age cohort) with an inadequate response or intolerance to at least one DMARD, which may have included biologic agents, were treated.
Slovenian: V tej študiji so se zdravili otroci in mladostniki z zmerno do hudo aktivnim pJIA, stari od 2 do 17 let (46 bolnikov v kohorti bolnikov, starih od 2 do 5 let, in 173 bolnikov v kohorti bolnikov, starih od 6 do 17 let) z nezadostnim odzivom ali intoleranco za vsaj enega od imunomodulirajočih protirevmatičnih zdravil, kar je lahko vključevalo tudi biološka zdravila.
English: How to use ORENCIA
Slovenian: Kako uporabljati zdravilo ORENCIA
English: Among the patients who entered the open-label 12 month period, 59% (125/213) of patients receiving continuous abatacept plus methotrexate treatment and 48% (92/192) of patients who initially received methotrexate and switched to combination with abatacept had no progression.
Slovenian: Med bolniki, ki so bili vključeni v odprto 12-mesečno obdobje do napredovanja bolezni ni prišlo pri 59% (125/213) bolnikov, ki so kontinuirano prejemali abatacept in metotreksat, in pri 48% (92/192) bolnikov, ki so v začetku prejemali metotreksat in so nato prešli na kombinirano zdravljenje z abataceptom.
English: ORENCIA should not be used in pregnant women unless clearly necessary.
Slovenian: Zdravila ORENCIA se ne sme uporabljati pri nosečnicah, če to ni nujno potrebno.
English: Patients were allowed to receive stable doses of concomitant methotrexate, sulfasalazine, leflunomide, hydroxychloroquine, low dose corticosteroids (equivalent to ≤ 10 mg of prednisone) and/or NSAIDs during the trial.
Slovenian: Bolniki so med preskušanjem lahko prejemali stabilne odmerke metotreksata, sulfasalazina, leflunomida, hidroksiklorokina, nizke odmerke kortikosteroidov (v odmerkih, enakovrednih ≤ 10 mg prednizona) in/ali nesteroidna protivnetna zdravila (NSAID).
English: During the cumulative study period when all subjects treated with abatacept in 7 SC studies were included, the frequency of injection site reactions was 4.6% (116/2,538) with an incidence rate of 1.32 per 100 person-years.
Slovenian: Med kumulativnim obdobjem študije, ko so bile vključene vse osebe, ki so se v 7 študijah subkutane uporabe abatacepta zdravile z abataceptom, je pogostnost reakcij na mestu injiciranja znašala 4,6% (116/2.538), stopnja pojavnosti pa 1,32 na 100 bolnik-let.
English: Abatacept has been studied in patients with active rheumatoid arthritis in placebo-controlled clinical trials (2,653 patients with abatacept, 1,485 with placebo).
Slovenian: Abatacept so raziskovali pri bolnikih z aktivnim revmatoidnim artritisom v s placebom nadzorovanih kliničnih preskušanjih (2.653 bolnikov je prejemalo abatacept, 1.485 placebo).
English: Study V patients were randomised to receive this same fixed dose of abatacept or 3 mg/kg infliximab or placebo for 6 months.
Slovenian: V študiji V so bili bolniki randomizirani tako, da so 6 mesecev prejemali ta isti fiksni odmerek abatacepta, 3 mg/kg infliksimaba ali placebo.
English: Allow the syringe to rest at room temperature for 30 to 60 minutes before you inject.
Slovenian: Injekcijsko brizgo pred injiciranjem pustite na sobni temperaturi za 30 do 60 minut.
English: o Patient alert card: o A warning message for healthcare professionals treating the patient at any time, including in conditions of emergency, that the patient is using ORENCIA o That ORENCIA treatment may increase the risk of infections and allergic reactions.
Slovenian: o Opozorilna kartica za bolnika: o Opozorilo vsem zdravstvenim delavcem, ki kakor koli zdravijo bolnika, tudi v nujnih primerih, da bolnik uporablja zdravilo ORENCIA.
English: Study SC-I was a randomised, double-blind, double-dummy noninferiority study administered to patients stratified by body weight (< 60 kg, 60 to 100 kg, > 100 kg) that compared the efficacy and safety of abatacept administered subcutaneously and intravenously in subjects with rheumatoid arthritis (RA), receiving background methotrexate (MTX), and experiencing an inadequate response to MTX (MTX-IR).
Slovenian: Študija SC-I je bila randomizirana, dvojno slepa, dvojno zakrita študija neinferiornosti pri bolnikih, razvrščenih v skupine glede na telesno maso (< 60 kg, 60 do 100 kg, > 100 kg), ki je primerjala učinkovitost in varnost subkutane in intravenske uporabe abatacepta pri bolnikih z revmatoidnim artritisom (RA), ki so se zdravili z metotreksatom (MTX), odziv na zdravljenje z metotreksatom pa ni bil zadosten (MTX-IR).
English: Check the liquid in the pre-filled syringe through the viewing window.
Slovenian: Preverite tekočino v napolnjeni injekcijski brizgi preko preglednega okenca.
English: 125 mg/mL orange plunger
Slovenian: 125 mg/ml oranžen bat
English: ORENCIA is supplied as a powder for solution for infusion.
Slovenian: Zdravilo ORENCIA je na voljo kot prašek za raztopino za infundiranje.
English: Clinical efficacy and safety in adult psoriatic arthritis
Slovenian: Klinična učinkovitost in varnost pri odraslih s psoriaznim artritisom
English: The open label period of the study provided an assessment of the ability of abatacept to maintain efficacy for subjects originally randomised to abatacept and the efficacy response of those subjects who were switched to abatacept following treatment with infliximab.
Slovenian: Na osnovi odprtega obdobja študije so ocenili, da abatacept ohrani učinkovitost pri osebah, ki so bile izvorno randomizirane na abatacept, in učinkovitost odziva pri tistih osebah, pri katerih je bilo zdravljenje z abataceptom uvedeno po predhodnem zdravljenju z infliksimabom.
English: Use your thumb to push the plunger down, pressing firmly until the plunger will go no further, and all of the medicine has been injected (Figure 6).
Slovenian: Pritisk na bat naj bo dovolj močan vse dokler bat ne gre več naprej in ste injicirali celotno količino zdravila (slika 6).
English: Serious infections at least possibly related to treatment were reported in 1.5% of abatacept-treated patients and 1.1% of placebo-treated patients.
Slovenian: O resnih okužbah, ki bi lahko bile povezane z zdravljenjem, so poročali pri 1,5% bolnikov, ki so prejemali abatacept, in 1,1% bolnikov, ki so prejemali placebo.